Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
60
PharmaCompass offers a list of Capmatinib Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Capmatinib Hydrochloride manufacturer or Capmatinib Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Capmatinib Hydrochloride manufacturer or Capmatinib Hydrochloride supplier.
A Capmatinib Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Capmatinib Hydrochloride, including repackagers and relabelers. The FDA regulates Capmatinib Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Capmatinib Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Capmatinib Hydrochloride supplier is an individual or a company that provides Capmatinib Hydrochloride active pharmaceutical ingredient (API) or Capmatinib Hydrochloride finished formulations upon request. The Capmatinib Hydrochloride suppliers may include Capmatinib Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Capmatinib Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Capmatinib Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Capmatinib Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Capmatinib Hydrochloride DMFs exist exist since differing nations have different regulations, such as Capmatinib Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Capmatinib Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Capmatinib Hydrochloride USDMF includes data on Capmatinib Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Capmatinib Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Capmatinib Hydrochloride suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Capmatinib Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Capmatinib Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Capmatinib Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Capmatinib Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Capmatinib Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Capmatinib Hydrochloride suppliers with NDC on PharmaCompass.
Capmatinib Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Capmatinib Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Capmatinib Hydrochloride GMP manufacturer or Capmatinib Hydrochloride GMP API supplier for your needs.
A Capmatinib Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Capmatinib Hydrochloride's compliance with Capmatinib Hydrochloride specifications and serves as a tool for batch-level quality control.
Capmatinib Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Capmatinib Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Capmatinib Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Capmatinib Hydrochloride EP), Capmatinib Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Capmatinib Hydrochloride USP).
